Small-Molecule Inhibitors: Ibrutinib in Chronic Lymphocytic Leukemia
3 Views
administrator
07/14/23
The panelists, William G. Wierda, MD, PhD; Susan M. O’Brien, MD; Alessandra Ferrajoli, MD; and Shuo Ma, MD, PhD, highlight clinical trial data involving the B-cell receptor inhibitor, ibrutinib, in the treatment of chronic lymphocytic leukemia.
Show more
Facebook Comments
No comments found